Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avenue Therapeutics Inc (ATXI)
NASDAQ:ATXI
Holding ATXI?
Track your performance easily
ATXI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.60 - $26.42
Previous Close$2.01
Volume2.98K
Average Volume (3M)44.24K
Market Cap
$3.68M
Enterprise Value$210.92K
Total Cash (Recent Filing)$2.60M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Mar 25, 2025EPS Estimate
-$0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.20
Shares Outstanding1,911,633
10 Day Avg. Volume31,953
30 Day Avg. Volume44,239
Standard Deviation0.36
R-Squared0.00066
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)1.47
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
Avenue Therapeutics News
PremiumCompany Announcements
Avenue Therapeutics Incentive Plan Awards Key Executives
PremiumCompany Announcements
Avenue Therapeutics Stockholders Approve Key Proposals
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ATXI FAQ
What was Avenue Therapeutics Inc’s price range in the past 12 months?
Avenue Therapeutics Inc lowest stock price was $1.60 and its highest was $26.42 in the past 12 months.
What is Avenue Therapeutics Inc’s market cap?
Currently, no data Available
When is Avenue Therapeutics Inc’s upcoming earnings report date?
Avenue Therapeutics Inc’s upcoming earnings report date is Mar 25, 2025 which is in 123 days.
How were Avenue Therapeutics Inc’s earnings last quarter?
Avenue Therapeutics Inc released its earnings results on Nov 14, 2024. The company reported -$1.92 earnings per share for the quarter, missing the consensus estimate of -$0.94 by -$0.98.
Is Avenue Therapeutics Inc overvalued?
According to Wall Street analysts Avenue Therapeutics Inc’s price is currently Overvalued.
Does Avenue Therapeutics Inc pay dividends?
Avenue Therapeutics Inc does not currently pay dividends.
What is Avenue Therapeutics Inc’s EPS estimate?
Avenue Therapeutics Inc’s EPS estimate is -$0.57.
How many shares outstanding does Avenue Therapeutics Inc have?
Avenue Therapeutics Inc has 1,911,633 shares outstanding.
What happened to Avenue Therapeutics Inc’s price movement after its last earnings report?
Avenue Therapeutics Inc reported an EPS of -$1.92 in its last earnings report, missing expectations of -$0.94. Following the earnings report the stock price went up 2.66%.
Which hedge fund is a major shareholder of Avenue Therapeutics Inc?
Currently, no hedge funds are holding shares in ATXI
---
Avenue Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Insider Transactions
Bought Shares
Worth $1.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 6.2%
Last 30 Days ▼ 6.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.66%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
422.91%
Trailing 12-Months
Company Description
Avenue Therapeutics Inc
Avenue Therapeutics, Inc. engages in acquiring, licensing, developing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, which is intended for the treatment of moderate to moderately severe post-operative pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.
---
ATXI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ATXI
1 Year
1 Year Success Rate
1/6 ratings generated profit
1 Year Average Return
-50.78%
reiterated a buy rating 7 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -50.78% per trade.
---